Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-3.06%
0%
-3.06%
6 Months
52.53%
0%
52.53%
1 Year
-8.26%
0%
-8.26%
2 Years
-25.53%
0%
-25.53%
3 Years
-60.68%
0%
-60.68%
4 Years
-79.74%
0%
-79.74%
5 Years
-53.46%
0%
-53.46%
MEDIAN Technologies SA for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
16.48%
EBIT Growth (5y)
-175.51%
EBIT to Interest (avg)
-9.95
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.73
Sales to Capital Employed (avg)
-0.95
Tax Ratio
0.57%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.18%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-1.78
EV to EBIT
-3.82
EV to EBITDA
-4.18
EV to Capital Employed
-9.41
EV to Sales
3.73
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
Negative BV
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bearish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
Shareholding Snapshot : Dec 2023
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.18%)
Strategic Entities with highest holding
Highest Public shareholder
Annual Results Snapshot (Consolidated) - Dec'23
Dec'23
Dec'22
Change(%)
Net Sales
22.20
23.70
-6.33%
Operating Profit (PBDIT) excl Other Income
-21.80
-22.50
3.11%
Interest
2.10
1.50
40.00%
Exceptional Items
2.20
4.70
-53.19%
Consolidate Net Profit
-23.00
-20.20
-13.86%
Operating Profit Margin (Excl OI)
-1,035.10%
-984.50%
-5.06%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2023 is -6.33% vs 15.61% in Dec 2022
Consolidated Net Profit
YoY Growth in year ended Dec 2023 is -13.86% vs -4.66% in Dec 2022
About MEDIAN Technologies SA 
MEDIAN Technologies SA
Pharmaceuticals & Biotechnology
Median Technologies SA is a France-based company that publishes software for the diagnosis and monitoring of cancer patients. The Company develops lesion management solutions (LMS) to objectively measure and track cancerous or suspicious lesions, distribute a standardized oncologic report and centralize the lesion information for multidisciplinary review. The LMS line includes such products as LMS-Lung, a clinical application for the detection, evaluation and follow-up of lesions identified in CT images covering the chest; LMS-Track, a clinical application for the follow-up of oncology patients; and LMS-Liver, a clinical application for the initial evaluation and the follow-up of liver metastases and any other lesions identified in CT images covering the liver. The Company operates one subsidiary, Median Technologies Inc, based in the United States.
Company Coordinates 
Company Details
Les Deux Arcs B, 1800 route des Cretes , VALBONNE None : 06560
Registrar Details






